YU56103A - Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata - Google Patents
Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrataInfo
- Publication number
- YU56103A YU56103A YU56103A YUP56103A YU56103A YU 56103 A YU56103 A YU 56103A YU 56103 A YU56103 A YU 56103A YU P56103 A YUP56103 A YU P56103A YU 56103 A YU56103 A YU 56103A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- hydrochloride dihydrate
- improved process
- ondansetron hydrochloride
- preparing pure
- pure ondansetron
- Prior art date
Links
- 229960005343 ondansetron Drugs 0.000 title abstract 3
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 abstract 1
- VHXLDRBDRZYEQE-UHFFFAOYSA-N 3-(dimethylamino)-2-methylcarbazol-1-one Chemical compound C1=CC=C2C3=CC(N(C)C)=C(C)C(=O)C3=NC2=C1 VHXLDRBDRZYEQE-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26105201P | 2001-01-11 | 2001-01-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU56103A true YU56103A (sh) | 2006-05-25 |
Family
ID=22991757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU56103A YU56103A (sh) | 2001-01-11 | 2002-01-11 | Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1355881A4 (cs) |
| JP (1) | JP2004526692A (cs) |
| KR (3) | KR20070054749A (cs) |
| CN (2) | CN1496350A (cs) |
| AU (1) | AU2002236753B2 (cs) |
| CA (1) | CA2433720A1 (cs) |
| CZ (1) | CZ20032090A3 (cs) |
| DE (1) | DE02703115T1 (cs) |
| ES (1) | ES2219201T1 (cs) |
| HR (1) | HRP20030631A2 (cs) |
| HU (1) | HUP0400767A2 (cs) |
| IL (1) | IL156835A0 (cs) |
| IS (1) | IS6869A (cs) |
| MX (1) | MXPA03006215A (cs) |
| NO (1) | NO20033147L (cs) |
| PL (1) | PL368837A1 (cs) |
| SK (1) | SK9892003A3 (cs) |
| TR (1) | TR200401460T3 (cs) |
| WO (1) | WO2002055492A2 (cs) |
| YU (1) | YU56103A (cs) |
| ZA (1) | ZA200305338B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2483566A1 (en) | 2002-04-29 | 2003-11-13 | Biogal Gyogyszergyar Rt. | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| HU225885B1 (en) * | 2002-10-17 | 2007-11-28 | Richter Gedeon Nyrt | Process for producing ondansetron hydrochlorid dihydrate of high purity |
| FI6164U1 (fi) * | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronmuotoja |
| GB2398071B (en) * | 2003-01-24 | 2006-06-07 | Synthon Bv | Process for making ondansetron and intermediate thereof |
| US7696356B2 (en) | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
| WO2006046253A1 (en) * | 2004-10-26 | 2006-05-04 | Ipca Laboratories Limited | A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
| SK6182003A3 (en) * | 2000-10-30 | 2004-03-02 | Teva Pharma | Crystalline and solvated forms of ondansetrone hydrochloride and preparation thereof |
-
2002
- 2002-01-11 SK SK989-2003A patent/SK9892003A3/sk not_active Application Discontinuation
- 2002-01-11 CN CNA028062019A patent/CN1496350A/zh active Pending
- 2002-01-11 YU YU56103A patent/YU56103A/sh unknown
- 2002-01-11 TR TR2004/01460T patent/TR200401460T3/xx unknown
- 2002-01-11 ZA ZA200305338A patent/ZA200305338B/xx unknown
- 2002-01-11 HR HR20030631A patent/HRP20030631A2/hr not_active Application Discontinuation
- 2002-01-11 CN CNA2006101667179A patent/CN101045704A/zh active Pending
- 2002-01-11 IL IL15683502A patent/IL156835A0/xx unknown
- 2002-01-11 DE DE02703115T patent/DE02703115T1/de active Pending
- 2002-01-11 CZ CZ20032090A patent/CZ20032090A3/cs unknown
- 2002-01-11 AU AU2002236753A patent/AU2002236753B2/en not_active Expired - Fee Related
- 2002-01-11 HU HU0400767A patent/HUP0400767A2/hu unknown
- 2002-01-11 WO PCT/US2002/000853 patent/WO2002055492A2/en not_active Ceased
- 2002-01-11 KR KR1020077010146A patent/KR20070054749A/ko not_active Ceased
- 2002-01-11 ES ES02703115T patent/ES2219201T1/es active Pending
- 2002-01-11 JP JP2002556165A patent/JP2004526692A/ja active Pending
- 2002-01-11 MX MXPA03006215A patent/MXPA03006215A/es unknown
- 2002-01-11 PL PL02368837A patent/PL368837A1/xx not_active Application Discontinuation
- 2002-01-11 EP EP02703115A patent/EP1355881A4/en not_active Withdrawn
- 2002-01-11 KR KR10-2003-7009221A patent/KR20030068583A/ko not_active Abandoned
- 2002-01-11 CA CA002433720A patent/CA2433720A1/en not_active Abandoned
- 2002-01-11 KR KR1020067020069A patent/KR20060113792A/ko not_active Ceased
-
2003
- 2003-07-08 IS IS6869A patent/IS6869A/is unknown
- 2003-07-09 NO NO20033147A patent/NO20033147L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002055492A3 (en) | 2003-02-13 |
| ZA200305338B (en) | 2004-07-12 |
| EP1355881A2 (en) | 2003-10-29 |
| ES2219201T1 (es) | 2004-12-01 |
| IS6869A (is) | 2003-07-08 |
| AU2002236753B2 (en) | 2007-06-28 |
| TR200401460T3 (cs) | 2004-08-23 |
| EP1355881A4 (en) | 2004-03-31 |
| HUP0400767A2 (hu) | 2004-07-28 |
| CN101045704A (zh) | 2007-10-03 |
| SK9892003A3 (en) | 2004-05-04 |
| CN1496350A (zh) | 2004-05-12 |
| KR20030068583A (ko) | 2003-08-21 |
| KR20070054749A (ko) | 2007-05-29 |
| CA2433720A1 (en) | 2002-07-18 |
| JP2004526692A (ja) | 2004-09-02 |
| IL156835A0 (en) | 2004-02-08 |
| PL368837A1 (en) | 2005-04-04 |
| CZ20032090A3 (cs) | 2004-08-18 |
| KR20060113792A (ko) | 2006-11-02 |
| WO2002055492A2 (en) | 2002-07-18 |
| NO20033147L (no) | 2003-09-02 |
| MXPA03006215A (es) | 2005-02-17 |
| NO20033147D0 (no) | 2003-07-09 |
| HRP20030631A2 (en) | 2005-06-30 |
| DE02703115T1 (de) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004011453A3 (en) | Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles | |
| HU0101336D0 (en) | Process for the preparation of perindopril and their pharmaceutically acceptable salts | |
| WO2004052899A3 (en) | Process for the production of 2'-branched nucleosides | |
| MXPA02012795A (es) | Carvedilol. | |
| NZ536141A (en) | Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles | |
| HU9601857D0 (en) | New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them | |
| IL114894A0 (en) | Endothelin antagonists | |
| MY134083A (en) | Crystalline clindamycin free base | |
| ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
| GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| YU56103A (sh) | Poboljšani postupak za pripremanje čistog ondansetron hidrohlorid dihidrata | |
| YU30203A (sh) | Kristalna venlafaksin baza i novi polimorfi venlafaksin hidrohlorida, postupci za njegovo pripremanje | |
| BG104243A (en) | Method for the synthesis of quinoline derivatives | |
| NO20062599L (no) | Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav | |
| IL159304A (en) | Process for the production of piperidine derivatives | |
| MY130488A (en) | Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols | |
| PL367114A1 (en) | Process for preparing a thialzole ppar-ligand and polymorphs thereof | |
| MXPA03006057A (es) | Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil. | |
| PL331330A1 (en) | Method of obtaining derivatives of 3-pyroline-2-carboxylic acid | |
| HU0201262D0 (cs) | ||
| CZ20011915A3 (cs) | Způsob výroby cyklenu | |
| EP2194038A3 (en) | Improved preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-P-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines | |
| YU71400A (sh) | Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana | |
| GB9906328D0 (en) | 2-Substituted RNA preparation | |
| IL146257A0 (en) | Method of producing methoxyimido acetic amide |